DTIL Form 144: 10,200 Shares Sold; 4,925 Vesting

DTIL reported Form 144 transactions involving restricted stock vesting and a recent resale.

Rhea-AI Filing Summary

DTIL reported Form 144 transactions involving restricted stock vesting and a recent resale. The filing shows 4,925 common shares listed under "Securities To Be Sold" with an event date of 02/17/2026 described as "Restricted Stock Vesting" and labeled "Issuer" and "Compensation". The filing also records that 10,200 common shares were sold by James Jefferson Revocable Trust on 01/21/2026 for $41,073.36.

Insights

Corporate Governance Analyst

Forms show a compensation vesting and a recent resale by an affiliated trust.

The filing lists 4,925 shares tied to a Restricted Stock Vesting event dated 02/17/2026 and labeled as Issuer and Compensation, indicating those shares arose from a compensation grant rather than an open-market purchase. Timing and transfer mechanism are stated in the entry.

Separately, the entry shows the James Jefferson Revocable Trust sold 10,200 common shares on 01/21/2026 for $41,073.36. Cash‑flow treatment and any subsequent holdings are not detailed in the excerpt; subsequent filings would show further activity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did DTIL disclose on the Form 144 about restricted stock?

The filing lists 4,925 common shares tied to a Restricted Stock Vesting event dated 02/17/2026. The entry is labeled Issuer and Compensation, indicating these shares were issued under a compensation arrangement.

Who sold shares recently according to the DTIL Form 144?

The filing shows the James Jefferson Revocable Trust sold 10,200 common shares on 01/21/2026 for $41,073.36. The trust is the named seller in the "Securities Sold During The Past 3 Months" section.

How many shares are noted as to be sold and on what date?

The form records 4,925 common shares under "Securities To Be Sold" with an associated date of 02/17/2026, described as a restricted stock vesting event and linked to compensation by the issuer.

Does the filing state who receives proceeds from the recorded sale?

The excerpt specifies the seller for the prior sale and an aggregate amount $41,073.36 for 10,200 shares on 01/21/2026. It does not state the recipient of proceeds for the restricted stock vesting entry.

Is the transaction type for the 02/17/2026 shares specified in DTIL's filing?

Yes. The entry for 02/17/2026 is labeled Restricted Stock Vesting and categorized under Compensation, indicating the shares arose from a vesting of restricted stock rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 05:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770169
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	SMITH J. JEFFERSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4925	18929.24	13256751	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			4925	02/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Jefferson Revocable Trust 302 East Pettigrew St., Suite A-100 Durham NC 27701	Common	01/21/2026	10200	41073.36

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. Today's sale, as well as all previous sales within the last 90 days, occurred in the account of the James Jefferson Revocable Trust of which James Jefferson Smith is a trustee and an account stakeholder.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tyler Johnson, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James J. Smith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)